A 5 mg BPC-157 vial ($30-50) lasts 10-20 days at 250-500 mcg daily
Semaglutide has emerged as a groundbreaking treatment for obesity, rapidly gaining attention for its impressive weight loss results
Overall, the data in the literature demonstrate that endometriosis causes a decline in the quality of oocytes and embryos
Important safety considerations include a boxed warning for medullary thyroid carcinoma risk, monitoring for pancreatitis (severe abdominal pain), gallbladder disease, and potential hypoglycemia when used with insulin or sulfonylureas
In relation to the bone, IGF-1 is an important mediator of the effects of GH and modulates bone growth through its paracrine action in the growth plate (220) as it was demonstrated that the selective deletion of the igf1 gene in the liver and a consequent decrease in systemic IGF-1 did not affect the animals body and femoral growth (221)
Wegovy is approved as a weight-loss drug for people ages 12 and up with obesity and for some adults who are categorized as overweight but not obese